- Home
- VANI vs ATOM Comparison
VANI vs ATOM Comparison
Compare VANI & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- ATOM
- Stock Information
- Founded
- VANI 1998
- ATOM 2001
- Country
- VANI United States
- ATOM United States
- Employees
- VANI N/A
- ATOM N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ATOM Semiconductors
- Sector
- VANI Health Care
- ATOM Technology
- Exchange
- VANI Nasdaq
- ATOM Nasdaq
- Market Cap
- VANI 81.2M
- ATOM 68.7M
- IPO Year
- VANI 2014
- ATOM 2016
- Fundamental
- Price
- VANI $1.40
- ATOM $2.19
- Analyst Decision
- VANI Strong Buy
- ATOM
- Analyst Count
- VANI 1
- ATOM 0
- Target Price
- VANI $4.00
- ATOM N/A
- AVG Volume (30 Days)
- VANI 435.3K
- ATOM 764.8K
- Earning Date
- VANI 11-13-2025
- ATOM 10-28-2025
- Dividend Yield
- VANI N/A
- ATOM N/A
- EPS Growth
- VANI N/A
- ATOM N/A
- EPS
- VANI N/A
- ATOM N/A
- Revenue
- VANI N/A
- ATOM $38,000.00
- Revenue This Year
- VANI N/A
- ATOM N/A
- Revenue Next Year
- VANI N/A
- ATOM $300.00
- P/E Ratio
- VANI N/A
- ATOM N/A
- Revenue Growth
- VANI N/A
- ATOM N/A
- 52 Week Low
- VANI $0.91
- ATOM $2.03
- 52 Week High
- VANI $1.92
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- VANI 44.06
- ATOM 31.64
- Support Level
- VANI $1.36
- ATOM $2.03
- Resistance Level
- VANI $1.50
- ATOM $2.84
- Average True Range (ATR)
- VANI 0.11
- ATOM 0.19
- MACD
- VANI -0.02
- ATOM -0.02
- Stochastic Oscillator
- VANI 13.52
- ATOM 18.80
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.